Lithium as an Adjuvant in the Postoperative Ablation of Remnant Tissue in Low-Risk Thyroid Carcinoma

Abstract

The addition of lithium to treatment with 30 mCi 131I in thyroidectomized patients with low-risk DTC improved the efficacy of thyroid RA and therefore might be a better alternative than using higher doses of 131I for remnant ablation in these patients.